
Modern oral testosterone undecanoate and injectable testosterone can provide replacement in men with confirmed hypogonadism. Oral products avoid injections but require attention to meals, regular administration and product-specific testing. Injections differ in duration, device and clinic requirements. Both can raise hematocrit and blood pressure and suppress sperm production. A capsule is not automatically safer, and oral products cannot be substituted milligram for milligram.1234
Key points
- Jatenzo, Kyzatrex and Tlando have different testosterone sampling instructions.123
- Blood-pressure changes reported in separate product studies cannot establish a head-to-head safety ranking.123
- Long-acting Aveed injection retains product-specific POME and anaphylaxis precautions.5
What does oral testosterone mean today?
In current US replacement therapy, an oral option may mean a testosterone undecanoate capsule such as Jatenzo, Kyzatrex or Tlando. These are distinct prescription formulations. They should not be confused with an over-the-counter testosterone booster or with older 17-alpha-alkylated androgens such as methyltestosterone. 1 2 3
That distinction resolves much of the conflicting advice about pills. A statement based on an older oral drug may not describe modern undecanoate, while a favorable study of one undecanoate formulation does not automatically apply to every capsule. Product labels explicitly warn against substituting one oral undecanoate product for another. 2 3
The physiological purpose remains replacement, as explained in what TRT is intended to treat. The ability to swallow a medicine instead of injecting it changes delivery. It does not remove the need for a sound diagnosis, an appropriate treatment goal or an explanation of reproductive effects.
Do testosterone capsules damage the liver?
The strongest historical liver concern involves 17-alpha-alkylated oral androgens. The AUA recommends against prescribing alkylated oral testosterone. Modern undecanoate products have different formulation and metabolic characteristics, so it is inaccurate to treat every oral testosterone product as the same liver risk. 6
It is equally inaccurate to describe modern capsules as having no liver considerations. Their prescribing information still includes hepatic adverse-effect counseling, and a patient's liver disease, other medicines and symptoms remain relevant. Jaundice, dark urine or significant unexplained abdominal symptoms warrant medical assessment rather than reassurance based on the word modern. 1 2
The practical comparison should identify the molecule and label first. A general claim that oral treatment is unsafe can wrongly exclude a suitable option; a general claim that it bypasses all risk can obscure blood pressure, hematocrit and other systemic effects. Neither shortcut answers the actual treatment question.
Why do meals and blood-test timing matter?
Meals and sampling are part of the treatment specification for oral testosterone undecanoate. The prescribing information for these three products instructs administration with food, but they use different monitoring windows and response rules. A testosterone result drawn at an arbitrary time can therefore be misleading. 1 2 3
| Example | Label-based monitoring distinction | What the distinction means |
|---|---|---|
| Jatenzo | Serum testosterone assessed six hours after the morning administration. 1 | A sample from a different point is not automatically comparable. |
| Kyzatrex | Serum testosterone assessed three to five hours after the morning administration. 2 | The prescriber uses the product-specific assessment and adjustment framework. |
| Tlando | Serum testosterone assessed eight to nine hours after the morning administration. 3 | The label evaluates continued use or discontinuation of its fixed regimen. |
| Conventional cypionate or enanthate injection | Guidelines describe sampling midway between injections. 4 | An injection interval and a capsule day require different interpretation. |
These are laboratory-context distinctions, not instructions for starting or adjusting medicine. The clinical team should provide the exact plan, including whether to take the morning medicine before that particular draw. Keep the medication time, meal context and sample time in the record.

Do oral products raise blood pressure more than injections?
Some oral studies show blood-pressure increases, but separate trials do not establish a fair route ranking. Jatenzo's label reports an average ambulatory increase of 4.9/2.5 mm Hg after four months; Tlando reports 4.3/1.4 mm Hg after four months; Kyzatrex reports 1.7/0.6 mm Hg after four months. These were different product studies, not a randomized comparison among the three. 1 2 3
Those numbers differ in population, study details and exposure. Reading the smallest mean as proof of the safest treatment for an individual is an unsupported leap. An average also conceals people with larger increases and those with little change. Baseline hypertension and its treatment matter to the decision.
FDA's February 2025 action required blood-pressure warning information across testosterone products, including nonoral routes. The removal of cardiovascular boxed-warning language did not make blood-pressure monitoring optional. The cardiovascular evidence should be interpreted alongside the exact product label and the patient's measured response. 7
Why must injections be separated into different categories?
An injectable alternative could be a shorter-acting cypionate or enanthate preparation, an enanthate autoinjector, or a long-acting undecanoate product. These differ in release profile and administration burden. A general capsule-versus-shot comparison is incomplete until it names the injectable option. 4
Aveed, for example, carries a boxed warning for serious pulmonary oil microembolism reactions and anaphylaxis. Its label requires administration in a healthcare setting and observation for 30 minutes afterward through a restricted REMS program. That requirement belongs to this long-acting product and should not be pasted onto every testosterone injection. 5
At the other end of the comparison, a patient trained to use a prescribed home injection has a different travel, supplies and appointment burden. The cypionate and enanthate guide explains why the device, route and inactive ingredients can matter as much as the ester name.
Do oral approval studies prove better energy or libido?
A study showing that a product restores average testosterone concentrations establishes an exposure outcome. It does not establish superiority for every symptom. For example, the Kyzatrex pivotal study used the proportion of patients whose average testosterone was in a specified range as its primary efficacy endpoint. That is different from a blinded trial designed around fatigue or sexual function. 2
A route decision should therefore preserve a separate response assessment. What symptom or consequence of deficiency is being treated? How will it be measured? What happens if concentrations are appropriate but the complaint remains? The same questions apply to an injectable prescription. 4
All of these products deliver external testosterone. Neither the capsule shape nor a shorter daily exposure pattern provides a general guarantee of preserved fertility. If future sperm production matters, that conversation should happen before treatment selection, with the underlying diagnosis and reproductive timetable in view. 4

How can you make the route comparison useful?
Compare two concrete plans: the actual products, the meal or injection routine, the sampling instructions, safety monitoring and full continuing cost. A person who cannot reliably follow a meal-linked schedule may experience a different burden from someone who finds injections impossible. A preference is useful when it is translated into the routine that must be sustained.
The cost comparison should include laboratory work and visits in addition to medicine. A capsule may remove injection supplies while adding a different medication expense; a clinic injection may add administration and travel. A generic monthly estimate cannot settle those tradeoffs without actual quotes.
Oral treatment requires coordinated timing. Correctly interpreting the response requires coordination of medicine, food and blood collection. Convenience should be judged by the whole week of treatment, not by the few seconds required to swallow a capsule.
Common questions
Are oral testosterone products the same as supplements?
Can I switch between oral brands using the same amount?
References
- 1.Tolmar. Jatenzo prescribing information. DailyMed.
- 2.Marius Pharmaceuticals. Kyzatrex prescribing information. DailyMed, effective August 26, 2026.
- 3.Verity Pharmaceuticals. Tlando prescribing information. DailyMed, effective February 25, 2026.
- 4.Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. JCEM. 2018.
- 5.Endo USA. Aveed prescribing information. DailyMed, effective July 15, 2025.
- 6.Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. Journal of Urology. 2018.
- 7.FDA. FDA issues class-wide labeling changes for testosterone products. February 28, 2025.
This article is for general education, not medical advice, diagnosis or a treatment recommendation. A licensed clinician can interpret the evidence in the context of your symptoms, tests, medicines and fertility plans.